Search Results
Novel promising agents for the treatment of ITP
Fostamatinib and efgartigimod: novel agents in the treatment of ITP
Novel investigational drugs and promising therapies for immune thrombocytopenia
Shifting the treatment landscape of ITP: novel agents and future outlooks
Rilzabrutinib: a novel promising BTK inhibitor being explored in ITP
Avatrombopag: a novel oral therapy for the treatment of ITP
Latest updates in the management of immune thrombocytopenia
ITP: novel treatments
Platelet Disorders || Symptoms and Treatment for Immune Thrombocytopenia || Kaizen Oncology Network
The management of ITP during and after the COVID-19 pandemic
Ask the Experts - Michael Tarantino, MD, Discusses Treating Patients with ITP Who Require Surgery
Exciting novel treatments being developed for MDS
